Extruded dry beans and serum lipoprotein and plasma haemostatic factors in hyperlipidaemic men

European Journal of Clinical Nutrition

Volumn 54, Issue 5, 2000, Pages 373-379

  Oosthuizen, W ^a   Scholtz, C S ^a   Vorster, H H ^a   Jerling, J C ^a   Vermaak, W J H ^b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Dry beans; Extrusion; Fibrinogen; Lipoproteins; PAI 1; Plasminogen activator inhibitor 1; Viscosity

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; FIBRINOGEN; HEMOSTATIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; BEAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PLASMA VISCOSITY; RANDOMIZATION;

EID: 0034063581     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600966     Document Type: Article

References (49)

1. Anderson JW & Gustafson NJ (1987): Hypercholesterolaemic effects of oat and bean products. Am. J. Clin. Nutr. 48, 749-753.
2. Anderson JW, Gustafson NJ, Spencer DB, Tietyen J & Bryant CA (1990): Serum lipid response of hypercholesterolaemic men to single and divided doses of canned beans. Am. J. Clin. Nutr. 51, 1013-1019.
3. Anderson JW, Story L, Sieling B, Chen W-JL, Petro MS & Story J (1984): Hypocholesterolaemic effects of oat-bran or bean intake for hypercholesterolaemic men. Am. J. Clin. Nutr. 40, 1146-1155.
4. Aznar J, Estellés A, Tormo G, Sapena P, Tormo V, Blanch S & Espana F (1988). Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. Br. Heart. J. 59, 535-541.
5. Bradshaw D, Bourne D, Schneider M & Sayed R (1995): Mortality pattern of chronic diseases of lifestyle in South Africa. In Chronic Diseases of Lifestyle in South Africa, ed. J Fourie & K Steyn. Medical Research Council, Cape Town, pp 5-35.
6. Cobiac L, McArthur R & Nestel PJ (1990): Can eating baked beans lower plasma cholesterol. Eur. J. Clin. Nutr. 44, 819-822.
7. Danesh J, Collins R, Appleby P & Peto R (1998): Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies. JAMA 279, 1477-1482.
8. Djoussé L, Ellison C, Zhang Y, Arnett DK, Sholinsky P & Borecki I (1998): Relation between dietary fiber consumption and fibrinogen and plasminogen activator inhibitor type 1: The National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Clin. Nutr. 68, 568-575.
9. Englyst HN, Bingham SA, Runswick SA, Collinson E & Cummings JH (1988): Dietary fibre (non-starch polysaccharides) in fruit, vegetables and nuts. J. Hum. Nutr. Diet. 1, 247-286.
10. Frohlich M, Sund M, Russ S, Hoffmeister A, Fischer HG, Hombach V & Koenig W (1997): Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler. Thromb. Vasc. Biol. 17, 2692-2697.
11. Geil PB & Anderson JW (1994): Nutrition and health implications of dry beans: a review. J. Am. Coll. Nutr. 13, 549-558.
12. Grundy SM, Barrett-Connor E, Rudel LL, Miettinen T & Spector AA (1988): Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis. Arteriosclerosis 8, 95-101.
13. Gujska E & Khan K (1990): Effect of temperature on properties of extrudates from high starch fractions of navy, pinto and garbanzo beans. J. Food Sci. 55, 466-469.
14. Harper JM (1995): Extrusion technology: Current status and future potential. S. Afr. J. Food Sci. Nutr. 7, 135-141.
15. Harris ED (1997): Lipoprotein (a): a predictor of atherosclero disease. Nutr. Rev. 55, 61-64.
16. Hegsted DM, Ausman LM, Johnson JA & Dallal GE (1993): Dietary fat and serum lipids: an evaluation of the experimental data. Am. J. Clin. Nutr. 57, 875-883.
17. Howell WH, McNamara DJ, Tosca MA, Smith BT & Gaines JA (1997): Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am. J. Clin. Nutr. 65, 1747-1764.
18. Jenkins DJA, Wong GS, Patten R, Bird J, Hall M, Buckley GC, McGuire V, Reichert R & Little JA (1983): Leguminous seeds in the dietary management of hyperlipidemia. Am. J. Clin. Nutr. 38, 567-573.
19. Koepp P & Hegewisch S (1981): Effects of guar on plasma viscosity and related parameters in diabetic children. Eur. J. Paed. 137, 31-33.
20. Kotze MJ, Langenhoven E, Theart L, Marx MP & Oosthuizen CJJ (1994): Report on molecular diagnostic service for familial hypercholesterolemia in Afrikaners. Genetic Counseling 5, 15-22.
21. Landin K, Holm G, Tengborn L & Smith U (1992): Guar gum improves insulin sensitivity, blood lipids, blood pressure and fibrinolysis in healthy men. Am. J. Clin. Nutr. 56, 1061-1065.
22. Langenhoven ML, Conradie PJ, Wolmarans P & Faber M (1991a): MRC Food Quantities Manual. 2nd ed, 213 p. National Research Institute for Nutritional Disease of the South African Medical Research Council, Parow.
23. Langenhoven ML, Kruger M, Gouws F. & Faber M (1991b): MRC Food Composition Tables. 3rd ed, 245 p. National Research Institute for Nutritional Disease of the South African Medical Research Council, Parow.
24. Lee AJ, Smith WCS, Lowe GDO & Tunstall-Pedoe H (1990): Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. J. Clin. Epidemiol. 43, 913-919.
25. Lee RD & Nieman DC (1993): Nutritional Assessment, WCB Brown & Benchmark, Madison, 232 p.
26. Lintas C & Cappelloni M (1992): Effects of processing on legume resistant starch. Eur. J. Clin. Nutr. 46 (Suppl. 2). S103-S104.
27. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA & Cummings JH (1998): Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br. J. Nutr. 79, 133-139.
28. Lowe GDO (1986): Bloodrheology in arterial disease. Clin. Sci. 71, 137-146.
29. Mackay S & Ball MJ (1992): Do beans and oat bran add to the effectiveness of a low-fat diet? Eur. J. Clin. Nutr. 46, 641-648.
30. Marckmann P. Sandström B & Jespersen J (1993): Favorable long-term effect of a low-fat/high-fibre diet on human blood coagulation and fibrinolysis. Arterioscl. Thromb. 13, 505-511.
31. Meade TW, Cooper JA, Chakrabarti R, Miller GJ, Stirling Y & Howarth DJ (1996): Fibrinolytic activity and clotting factors in ischaemic heart disease in women. Br. Med. J. 312, 1581.
32. Meade TW, Ruddock V, Stirling Y, Chakrabarti R & Miller GJ (1993): Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342, 1076-1079.
33. Mensink RP & Kalan MB (1992): Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscl. Thromb. 12, 911-919.
34. Moller L & Kristensen TS (1991): Plasma fibrinogen and ischemie heart disease risk factors. Arterioscl. Thromb. 11, 344-350.
35. Morgan SA, Sinclair AJ & O'Dea K (1993): Effect on serum lipids of addition of safflower oil or olive oil to very-low-fat diets rich in lean meat. J. Am. Diet. Assoc. 93, 644-648.
36. Murray CJL & Lopez AD (1996): Estimating causes of death: new methods and global and regional applications for 1990. In The Global Burden of Disease, ed. CJL Murray & AD Lopez. Harvard University Press, USA, pp 117-200, 5.1.
37. Scarabin P-Y, Aillaud M-F, Amouyel P. Evans A, Luc G, Ferriéres J, Arveiler D & Julian-Vague I (1998): Associations of fibrinogen, factor VII and PAI-I with baseline findings among 10.500 male participants in a prospective study of myocardial infarction - the PRIME study. Thromb. Haemost. 80, 749-756.
38. Shrapnel WS, Calvert GD, Nestel PJ & Truswell AS (1992): Diet and coronary heart disease. Med. J. Austr. 156, S9-S16.
39. Shutler SM. Bircher GM, Tredger JA, Morgan LM, Walker AF & Low AG (1989): The effect of daily baked bean (Phaseolus vulgaris) consumption on the plasma lipid levels of young, normo-cholesterolaemic men. Br. J. Nutr. 61, 257-265.
40. Sundell IB & Rånby M (1993): Oat husk fiber decreases plasminogen activator inhibitor type 1 activity. Haemostasis 23, 45-50.
41. Uebersax S, Ruengsakulrack S & Occeña LG (1991): Strategies and procedures for processing dry beans. Food Tech. 45, 104-111.
42. Venter CS, Vorster HH & Van der Nest DG (1990): Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed 'western' diets. J. Nutr. 120, 1046-1053.
43. Venter CS, Vorster HH, Van der Nest DG & Wight AW (1991): Effects of konjac-glucomannan and propionate on plasma fibrinogen and serum and liver lipids in Zucker rats. S. Afr. J. Clin. Nutr. 4, 6-11.
44. Vorster HH & Venter CS (1994): Health benefits of dry beans (Phaseolus vulgaris): a review. S. Afr. J. Food Sci. Nutr. 6, 72-76.
45. Vorster HH, Cummings JH & Veldman FJ (1997): Diet and haemostasis: time for nutrition science to get more involved. Br. J. Afr. 77, 671-684.
46. Vorster HH, Silvis N, Venter CS, Van Ryssen JJ, Huisman H. Van Eeden TS & Walker ARP (1987): Serum cholesterol, lipoproteins and plasma coagulation factors in South Africa blacks on a high egg but low-fat intake. Am. J. Clin. Nutr. 46, 52-57.
47. Vorster HH, Venter CS, Jerling JC, Oosthuizen W, Kruger HS, Veldman FJ & Vermaak WJH (1994): Changes in Plasma Fibrinogen During Six Months of Successful Hypolipidaemic Treatments. Third International Symposium: Multiple risk factors in cardiovascular disease, 6-9 July, Florence, Italy (abstract).
48. Wilhelmsen L, Svärsudd K, Korsan-Bengsten K, Larsson B, Welin L & Tibblin G (1984): Fibrinogen as risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311, 501-505.
49. Woodhouse PR, Meade TW & Khaw KT (1997): Plasminogen activator inhibitor-1, the acute phase response and vitamin C. Atherosclerosis 133, 71-76.